Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks. The findings appear in Arthritis & Rheumatology, an official journal of the American College of Rheumatology.
In a Geriatrics & Gerontology International study of 752 older adults with hypertension followed from 2008–2010 through 2012–2013, using sleeping pills on a regular basis was linked with use of an increasing number of blood pressure medications over time.
People under age 40 who are diagnosed with Type 2 diabetes are more likely to have or die from cardiovascular disease than those of similar age without diabetes and the excess risks were more pronounced in younger women, according to new research in the American Heart Association’s journal Circulation.
Despite guidelines indicating that statins can lower risk of heart attack and stroke, many patients who could benefit do not take them. More than half of eligible patients say they were never offered the cholesterol-lowering drugs; the experience of side effects or fear of side effects were reasons for stopping or refusing statins, according to new research in Journal of the American Heart Association.
Dementia risk in mid-life patients with atrial fibrillation (AF) can be reduced by controlling high blood pressure, according to a study presented at EHRA 2019, a congress of the European Society of Cardiology (ESC).
A drug commonly used to treat high blood pressure and angina is associated with an increased risk of out-of-hospital sudden cardiac arrest, according to results from the European Sudden Cardiac Arrest network (ESCAPE-NET) presented at EHRA 2019.